Sat.Jan 13, 2024

article thumbnail

STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery

STAT

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines. The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Packaging 269
article thumbnail

8 NFL Players-Turned-Doctors

Board Vitals - Pharmacist

Athletes and doctors are known for their drive, determination, and dedication. While several athletes have found success in multiple sports, a number of football players have traded their helmets for stethoscopes, making the switch from the gridiron to the physicians’ office. Take a look at some NFL players-turned-doctors, and then try your hand at a sample BoardVitals Sports Medicine board review question.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: What STAT readers think about JPM’s locked lactation room, covering weight loss drugs, and more

STAT

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “ Pumping milk at JPM was a nightmare.

208
208
article thumbnail

New patent for Teva Branded drug AUSTEDO

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and Teva and is included in two NDAs. It is available from one supplier. There… The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New patent for Boehringer Ingelheim drug PRADAXA

Drug Patent Watch

Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from three suppliers. There are four patents… The post New patent for Boehringer Ingelheim drug PRADAXA appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

New patent for Kaleo Inc drug AUVI-Q

Drug Patent Watch

Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents… The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentWatch - Make Better Decisions.

59

More Trending

article thumbnail

New patent for TEVA drug AUSTEDO XR

Drug Patent Watch

Annual Drug Patent Expirations for AUSTEDO+XR Austedo Xr is a drug marketed by Teva and is included in one NDA. It is available from one supplier. There are nine patents… The post New patent for TEVA drug AUSTEDO XR appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

New patent for Avion Pharms drug DHIVY

Drug Patent Watch

Annual Drug Patent Expirations for DHIVY Dhivy is a drug marketed by Avion Pharms and is included in one NDA. It is available from one supplier. There are two patents… The post New patent for Avion Pharms drug DHIVY appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

New patent for Sun Pharm drug WINLEVI

Drug Patent Watch

Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent for Sun Pharm drug WINLEVI appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Which pharmaceutical companies have the most drug patents in Philippines?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Philippines? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.